● Recruiting

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

Condition: Atopic Dermatitis · Sponsor: Oneness Biotech Co., Ltd.

PhasePhase 2

Planned participants114

Who can joinAll sexes, 18 Years to 65 Years

Healthy volunteersNo

About this study

This is a randomized, placebo-controlled and double-blind study to evaluate the efficacy, pharmacokinetics, and Safety of repeat subcutaneous doses of FB825 in adults with moderate-to-severe atopic dermatitis.

This description comes directly from the study's public registry record.

Talk to the study team

Jessica Ho · 02-2703-1098 · jessica.ho@onenessbio.com.tw

Reo Yang · 02-2703-1098 · reo.yang@onenessbio.com.tw

Always discuss trial participation with your own doctor first.

Locations (16)

First OC Dermatology	Fountain Valley, California, United States	Recruiting
Center for Dermatology Clinical Research, Inc.	Fremont, California, United States	Recruiting
California Allergy and Asthma Medical Group	Los Angeles, California, United States	Recruiting
University of California, Davis Health, Department of Dermatology	Sacramento, California, United States	Recruiting
UT Health Science Houston	Bellaire, Texas, United States	Recruiting
Center for Clinical Studies	Webster, Texas, United States	Recruiting
Kaohsiung Chang Gung Memorial Hospital	Kaohsiung City, Taiwan	Recruiting
Kaohsiung Veterans General Hospital	Kaohsiung City, Taiwan	Recruiting
Linkou Chang Gung Memorial Hospital	New Taipei City, Taiwan	Recruiting
Taipei Medical University-Shuang Ho Hospital	New Taipei City, Taiwan	Recruiting
China Medical University Hospital	Taichung, Taiwan	Recruiting
National Cheng Kung University Hospital	Tainan, Taiwan	Recruiting

+ 4 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06397911